Literature DB >> 9365096

Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits.

T Yamamoto1, T Irisa, Y Sugioka, K Sueishi.   

Abstract

OBJECTIVE: To investigate the effects of pulse methylprednisolone acetate on bone and bone marrow tissues and to clarify the causal factors of corticosteroid-induced osteonecrosis (ON) by using an experimental animal model.
METHODS: Male adult Japanese white rabbits were injected once with 20 mg/kg of methylprednisolone into the right gluteus medius muscle. Seven rabbits were killed at 4 weeks, 4 at 6 weeks, 4 at 8 weeks, and 6 at 10 weeks. Both histopathologic and hematologic studies were performed every week.
RESULTS: By 4 weeks after the steroid injection, 43% of the rabbits studied had developed multifocal ON lesions in the femur and/or humerus. In 1 rabbit, a thrombus was detected in an arteriole adjacent to the necrotic area at 4 weeks. After 6 weeks, there was also progressive histologic evidence of revascularization, with granulation tissue, and osteoblastic repair, with appositional bone formation. Hyperlipemia, fatty liver, and intraosseous fat embolism were observed in conjunction with thrombocytopenia and hypofibrinogenemia.
CONCLUSION: A single injection of high-dose corticosteroids was found to be capable of inducing thrombocytopenia, hypofibrinogenemia, and hyperlipemia with multifocal ON in several bones.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365096     DOI: 10.1002/art.1780401119

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  79 in total

1.  Immunomodulation of tissue-engineered transplants: in vivo bone generation from methylprednisolone-stimulated chondrocytes.

Authors:  Andreas Haisch; Frank Wanjura; Cornelia Radke; Korinna Leder-Jöhrens; Andreas Gröger; Michaela Endres; Svea Klaering; Alexander Loch; Michael Sittinger
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-25       Impact factor: 2.503

2.  The repair process of osteonecrosis after a transtrochanteric rotational osteotomy.

Authors:  Takuaki Yamamoto; Satoshi Ikemura; Yukihide Iwamoto; Yoichi Sugioka
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

3.  Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits.

Authors:  Pengde Kang; Hong Gao; Fuxing Pei; Bin Shen; Jing Yang; Zongke Zhou
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

4.  Electromagnetic fields: a novel prophylaxis for steroid-induced osteonecrosis.

Authors:  Masashi Ishida; Mikihiro Fujioka; Kenji A Takahashi; Yuji Arai; Toshikazu Kubo
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

5.  Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.

Authors:  Shih-Hsiang Chen; Tsung-Yen Chang; Tang-Her Jaing; Mel S Lee; Chao-Jan Wang; Iou-Jih Hung; Chao-Ping Yang
Journal:  Int J Hematol       Date:  2015-04-04       Impact factor: 2.490

Review 6.  [Femoral head necrosis].

Authors:  J Kramer; G Scheurecker; A Scheurecker; A Stöger; A Huber; S Hofmann
Journal:  Radiologe       Date:  2009-05       Impact factor: 0.635

7.  Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome.

Authors:  Kazuetsu Mori; Masataka Honda; Masahiro Ikeda
Journal:  Pediatr Nephrol       Date:  2004-08-18       Impact factor: 3.714

8.  Alterations of sympathetic nerve fibers in avascular necrosis of femoral head.

Authors:  Deqiang Li; Peilai Liu; Yuankai Zhang; Ming Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Vitamin E prevents steroid-induced osteonecrosis in rabbits.

Authors:  Masaaki Kuribayashi; Mikihiro Fujioka; Kenji A Takahashi; Yuji Arai; Masashi Ishida; Tsuyoshi Goto; Toshikazu Kubo
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

10.  Constitutional flavonoids derived from Epimedium dose-dependently reduce incidence of steroid-associated osteonecrosis not via direct action by themselves on potential cellular targets.

Authors:  Ge Zhang; Xin-Luan Wang; Hui Sheng; Xin-Hui Xie; Yi-Xin He; Xin-Sheng Yao; Zi-Rong Li; Kwong-Man Lee; Wei He; Kwok-Sui Leung; Ling Qin
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.